[
    {
        "molecule_name": "bifunctional homodimers and monofunctional and bifunctional heterodimers (PEAK 2)",
        "protein_target_name": "b-amyloid",
        "binding_metric": "EC50",
        "value": "19",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The b-amyloid binding activity of the CEX fractions containing a mixture of bifunctional homodimers, and monofunctional and bifunctional heterodimers (PEAK 2, Fig 23A, (EC 50 19nM) was very similar to that of the bifunctional homodimer (PEAK 3, Fig.23A, EC 50 13nM), demonstrating that the heterodimer and homodimer fractions (PEAKS 2 and 3of the CEX) can be combined without significantly losing b-amyloid binding activity.\n\nNote that there is only one sentence that meets the criteria, which includes the molecule name (FC5-(H3)-hFc1x7-ABP), bioactivity metric (EC50), specific numeric value (19nM and 13nM), and unit (nM)."
    },
    {
        "molecule_name": "bifunctional homodimer (PEAK 3)",
        "protein_target_name": "b-amyloid",
        "binding_metric": "EC50",
        "value": "13",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The b-amyloid binding activity of the CEX fractions containing a mixture of bifunctional homodimers, and monofunctional and bifunctional heterodimers (PEAK 2, Fig 23A, (EC 50 19nM) was very similar to that of the bifunctional homodimer (PEAK 3, Fig.23A, EC 50 13nM), demonstrating that the heterodimer and homodimer fractions (PEAKS 2 and 3of the CEX) can be combined without significantly losing b-amyloid binding activity.\n\nNote that there is only one sentence that meets the criteria, which includes the molecule name (FC5-(H3)-hFc1x7-ABP), bioactivity metric (EC50), specific numeric value (19nM and 13nM), and unit (nM)."
    }
]